BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Acyl-CoA synthetase short-chain family member 2 (ACSS2)

March 12, 2015 7:00 AM UTC

Studies in cell culture, mice and patient samples suggest inhibiting ACSS2 could help treat cancer. ACSS2 converts acetate to acetyl-CoA as part of the Krebs cycle, which oxidizes acetate to produce e...